# A Study to Evaluate the Safety and Pharmacokinetics of RadProtect® in Healthy Volunteers

> **NCT02587442** · PHASE1 · UNKNOWN · sponsor: **Original BioMedicals Co. Ltd.** · enrollment: 27 (estimated)

## Conditions studied

- Acute Radiation Syndrome

## Interventions

- **DRUG:** RadProtect®

## Key facts

- **NCT ID:** NCT02587442
- **Lead sponsor:** Original BioMedicals Co. Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-10
- **Primary completion:** 2016-03
- **Final completion:** —
- **Target enrollment:** 27 (ESTIMATED)
- **Last updated:** 2015-10-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02587442

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02587442, "A Study to Evaluate the Safety and Pharmacokinetics of RadProtect® in Healthy Volunteers". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02587442. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*